Mobile website
Archive > Volume 27 Issue 11 > 2020,27(11):1199-1205. DOI:10.3872/j.issn.1007-385X.2020.11.001 Prev Next
Expert Forum
The promotion of precise diagnosis and treatment of thyroid cancer by mass spectrometry-based high throughput proteomics technologies
- Article
- Figures
- Metrics
- Preview PDF
- Reference
- Related
- Cited by
- Materials
Abstract:
Thyroid cancer is a common endocrine malignant tumor, and its incidence is increasing year by year. Understanding the pathogenesis of thyroid cancer is essential for improving the accuracy of diagnosis, precise risk stratification, and the realization of personalized treatment. Recently, with the consistent development of mass spectrometry-related technologies, a variety of proteomics analysis methods based on different specimen types (cells, tissues, serum and urine) have been widely used in the research of thyroid cancer, thereby actively promote the development of precision diagnosis and treatment of thyroid cancer through elucidating the pathogenesis, diagnostic classification, prognosis prediction and targeted therapy etc.
Keywords:
Project Supported:
Project supported by the National Natural Science Foundation of China (No. 81702651), and the Special Health Project Directly from Jilin Province (No.2018SCZ007)
Clc Number:
